Dissertations / Theses on the topic 'Hypertrophie du ventricule gauche'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Hypertrophie du ventricule gauche.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Brunot, Claire. "Suivi d'une cohorte bordelaise d'hypertendus : valeur prédictive de l'hypertrophie ventriculaire gauche et de son évolution sous traitement." Bordeaux 2, 1999. http://www.theses.fr/1999BOR23060.
Full textHillairet, Gwénaëlle. "Valeur pronostique de l'évolution de l'hypertrophie ventriculaire gauche chez l'hypertendu." Bordeaux 2, 1997. http://www.theses.fr/1997BOR2M086.
Full textSchnell, Frédéric. "Hypertrophie ventriculaire gauche physiologique ou pathologique : Intérêt d’une approche multiparamétrique." Thesis, Rennes 1, 2015. http://www.theses.fr/2015REN1B021/document.
Full textIntroduction: the diagnosis of hypertrophic cardiomyopathy (HCM) in athlete is difficult. Indeed, intense sports practice induces an electrical and morphological physiological remodeling which can be difficult to differentiate from the changes induced in pathology. However, it is essential to diagnose an athlete with a cardiomyopathy. Indeed, in case of underlying cardiomyopathy the athlete will be at risk of sudden cardiac death, but an excessive over diagnosis has strong professional and social consequences. Methods: (1) we have tried to improve the ECG criteria’s, which enable the differentiation between ECG changes induced by exercise and the ECG changes induced by an underlying cardiomyopathy. (2) We tried to define the best investigation algorithm in case of abnormal ECG changes in athletes. (3) We tried to improve the characterization of the phenotype of athletes with HCM as compared to sedentary HCM. (4) We tried to investigate if the use of new imaging technics, i.e. speckle tracking, might improve the diagnostic accuracy and enable a better prognostic evaluation in HCM. Results: We have proposed a new classification of ECG in athletes enabling to decrease the rate of false positive ECG in athletes without decreasing its diagnostic accuracy in HCM. In case of pathological T wave inversion (PTWI) in athletes, we demonstrated that a CMR is mandatory, as echocardiography missed a diagnosis of pathology in 35% of PTWI athletes. Nevertheless, the diagnosis of HCM with current criteria’s of HCM can be challenging. Indeed, HCM athletes have a different phenotype from HCM sedentary, with a better systolic and diastolic function; they also have a better longitudinal function. The assessment of longitudinal function during exercise and mechanical dispersion are promising tool for the diagnosis of HCM in athletes. Indeed, the alteration of longitudinal strain is related to myocardial fibrosis. Exercise echocardiography, i.e. exercise mitral insufficiency, seems to be a prognostic factor in HCM patients. Conclusions: Ours results enabled to develop tools which might help to better differentiate pathological and physiological left ventricular hypertrophy (LVH); but also to better characterize LVH and the prognosis in HCM patients
Dhahri, Wahiba. "Le métabolisme énergétique comme cible potentielle d'intervention thérapeutique pour l'hypertrophie ventriculaire gauche dans un modèle d'insuffisance aortique sévère chez le rat." Doctoral thesis, Université Laval, 2015. http://hdl.handle.net/20.500.11794/26181.
Full textAortic valve regurgitation (AR) is defined by the abnormal reflux of blood from the aorta into the left ventricle (LV) during diastole due to loss of etancheity causing volume overload (VO) disease and eccentric left ventricular hypertrophy (LVH). Parallel to the structural and functional remodeling associated with LVH, a metabolic remodeling is also observed. Furthermore, to our knowledge, the impact of a pharmacological intervention that targets the damaged myocardial metabolism in LVH caused by VO has not been studied. There are also gaps in knowledge about the functional and metabolic changes manifested in chronic AR with the establishment of obesity or type 2 diabetes (T2D). In this perspective, this work tested the general hypothesis that treatment with metformin or fenofibrate targeting two essential pathways in energy metabolism (AMPK and PPARα respectively) will improve function and myocardial metabolism and that administration of a high-fat diet (obesogenic) will negatively influence the function and cardiac remodeling and energy metabolism. The main objectives of this thesis are to assess the short-term (8 weeks) effects of two pharmacological treatments: fenofibrate and metformin as well as the impacts of a long term (30 weeks) consumption of a diet enriched in fat, on clinical and echocardiographic parameters and myocardial energy metabolism in an animal model of chronic VO caused by surgical induction of severe AR in rats. My studies have shown in the AR rat that both treatments reduced the dilation and eccentric LV remodeling but without preventing LVH. It was observed that the consumption for 30 weeks of a high-fat diet had a negative impact on the survival and development of LVH and myocardial metabolism in AR rats compared to the control diet. These results lead us to believe that the nature of the food taken by AR patients may influence the development of the disease and survival.
FERMOND, BRUNO. "Arythmie ventriculaire et hypertrophie ventriculaire gauche chez l'hypertendu essentiel : etude sur 90 patients." Toulouse 3, 1990. http://www.theses.fr/1990TOU31180.
Full textCoulon, Patrice. "Etude de la masse ventriculaire gauche dans la cardiopathie hypertensive : place de l'échographie, intérêt." Université Louis Pasteur (Strasbourg) (1971-2008), 1992. http://www.theses.fr/1992STR1M133.
Full textChemaly, Elie R. "Etude critique des actions divergentes des surcharges ventriculaires de pression et de volume : rôle de la résistine." Paris 6, 2012. http://www.theses.fr/2012PA066557.
Full textCLAIREFOND, FRANCOIS. "Variabilite tensionnelle et morbidite." Aix-Marseille 2, 1990. http://www.theses.fr/1990AIX20282.
Full textDu, Cailar Guilhem. "Hypertrophie ventriculaire gauche et hypertension artérielle : déterminants nutritionnels et hormonaux." Montpellier 1, 1995. http://www.theses.fr/1995MON1T007.
Full textBARBA, SERGE. "Masse ventriculaire gauche, pression arterielle de repos et pression arterielle d'effort : correlations chez l'hypertendu." Lyon 1, 1991. http://www.theses.fr/1991LYO1M290.
Full textKindo, Michel. "Transmuralité de la fonction mitochondriale myocardique dans le coeur sain et hypertrophique." Strasbourg, 2011. http://www.theses.fr/2011STRA6259.
Full textThe myocardium is nonuniform with respect to its structure and function. Mitochondria are the main energy powerhouses of cells and are major source of reactive oxygen species. The mitochondrial function in the different layers of the left ventricular wall has been poorly described in the normal heart and in mild left ventricular hypertrophy. Nitric oxide has highly specific signaling pathways in the heart which is promoted by the compartmentalization of nitric oxide synthetases in the myocytes. The purpose of this study was to determine whether a left ventricular transmural gradient is present in myocardium and to determine how this gradient affects mitochondrial function. Furthermore we characterized the changes that occur in various left ventricular layers during the adaptation of mitochondrial function from the basal state to mild left ventricular hypertrophy. Basal nitric oxide synthetase 1 mRNA expression was significantly higher in the subendocardium and was associated with 2-fold higher nitric oxide production in the subendocardium compared with the subepicardium. Increased nitric oxyde in the subendocardium inhibited the mitochondrial respiratory complexes, which subsequently increased mitochondrial hydrogen peroxide and superoxide anion production in the subendocardium. This overproduction of reactive oxygen species was associated with an activation of antioxidant defence and mitochondrial biogenesis in the subendocardium. Finally, nitric oxide production and the balance between reactive oxygen species production and antioxidant activity maintained constant the sensitivity of the mitochondrial permeability transition pore in the left ventricular wall. Mild left ventricular hypertrophy reduced maximal oxidative capacity, increased mitochondrial hydrogen peroxide production, and increased sirtuin 3 and Cu/Zn-superoxide dismutase expression in the subendocardium and subepicardium, respectively. The mitochondrial biogenesis in the left ventricular wall was unchanged. The transmural energetic gradient for complex IV activity was significantly lower in cardiac hypertrophy. In summary, nitric oxide synthetase 1-derived nitric oxide is elevated in the subendocardium of the left ventricle at basal state and induces a balanced inhibition of the mitochondrial function. The transition to mild cardiac hypertrophy is characterized by alterations in the mitochondrial oxidative capacity and by increased oxidative stress. Increased sirtuin 3 expression and antioxidant defence systems might contribute to protection against maladaptive left ventricular hypertrophy
Laflamme, Marie-Hélène. "Impact de l'axe de la parathormone sur la masse ventriculaire gauche suite à une chirurgie de remplacement de la valve aortique." Master's thesis, Université Laval, 2016. http://hdl.handle.net/20.500.11794/26748.
Full textLeft ventricular hypertrophy is a frequent complication in patients suffering from aortic stenosis. When these patients undergo an aortic valve replacement, the extent to which the left ventricular hypertrophy regresses depends on hemodynamic factors, which are often irreversible. In this work, we investigated the contribution of parathormone to left ventricular hypertrophy in these patients. In this cross-sectional study, we investigated 195 patients at a mean of 8±3.5 years following their aortic valve replacement. Left ventricular function and mass were measured by Doppler echocardiography. We dosed the plasma levels of parathormone, vitamin D, calcium and phosphate. The results showed an independent and significant association between parathormone blood level and left ventricular mass and hypertrophy. Furthermore, plasma level of vitamin D and renal function were inversely correlated with plasma level of parathormone.
Jozwiak, Mathieu. "Caractérisation et modulation pharmacologique de la fonction ventriculaire gauche et du couplage contraction-relaxation par la mesure de la torsion et de la détorsion au cours de l’hypertension artérielle chronique." Thesis, Paris Est, 2017. http://www.theses.fr/2017PESC0013/document.
Full textChronic hypertension induces left ventricular (LV) hypertrophy, resulting in abnormalities in LV relaxation, passive stiffness and filling. The higher the heart rate, the more pronounced the LV diastolic dysfunction. Moreover, in the normal heart, there is a tight coupling between LV contraction and relaxation, implying that in case of preserved contraction-relaxation coupling during LV hypertrophy, there is no diastolic dysfunction without systolic dysfunction. Thus, the three main objectives of this thesis were to investigate 1) the LV function and contraction-relaxation coupling with LV twist and untwist, which represent LV myocardial deformation during systole and diastole, 2) the cellular mechanisms of the LV contraction-relaxation coupling and 3) the effects effects of heart rate reduction on LV twist and untwist in the context of chronic hypertension and LV hypertrophy. All experiments were conducted in a pig model of chronic hypertension and LV hypertrophy induced by four weeks of continuous angiotensin II infusion. Chronic angiotensin II infusion decreased LV twist and untwist but also delayed LV untwist in the cardiac cycle, whereas the LV ejection fraction was preserved. The contraction-relaxation coupling was preserved as illustrated by the strong relationship between LV twist and untwist. The contraction-relaxation coupling was also preserved at the level of cardiomyocytes. This implies that LV hypertrophy is associated with concomitant LV diastolic and systolic dysfunction despite preserved LV ejection fraction. Thus, LV diastolic dysfunction is always accompanied by LV systolic dysfunction, i.e., the discovery of LV diastolic dysfunction with preserved ejection fraction might imply the track of LV systolic dysfunction. At the cellular level, LV systolic and diastolic dysfunctions were associated to aberrant calcium handling with a remodelling of the type 2 ryanodine receptor calcium release channel (RyR2), i.e., PKA-hyperphosphorylation and depletion of calstabin 2 (FKBP12.6). RyR2 were leaky and hypersensitive to cytosolic calcium, during both the contraction and the relaxation phases. Since both LV systolic and diastolic dysfunctions were associated to leaky and hypersensitive RyR2 channels, it might suggest considering RyR2 as an integrator contributing to control contraction-relaxation coupling during chronic hypertension and LV hypertrophy. Finally, we investigated the effects of heart rate reduction induced by ivabradine, an If-channel blocker, which does not modify atrioventricular or LV conduction and is devoid of any intrinsic negative inotropic or lusitropic effects. In the context of chronic hypertension and LV hypertrophy, ivabradine improved both LV systolic and diastolic functions, as attested by the improvement in contraction and relaxation times, LV twist and untwist as well as LV filling. Heart-rate independent effects of ivabradine, i.e., pleiotropic effects, participate to its beneficial effect. However, the cellular mechanisms of these beneficial effects of ivabradine were not elucidated and require further investigations. In normal heart, when heart rate was reduced to a low level (approximately <60 beats/min) with ivabradine, LV twist was not affected but LV diastolic function was altered as suggested by decreased LV untwist parameters and increased LV end-diastolic pressure. Investigation of contraction-relaxation coupling during decompensation from stable LV hypertrophy remains a goal to achieve
PAGE, JEAN-DANIEL. "Relations entre excretion urinaire d'albumine et hypertrophie ventriculaire gauche dans une population d'hypertendus essentiels et de diabetiques non insulino-dependants hypertendus." Angers, 1990. http://www.theses.fr/1990ANGE1107.
Full textCAUCHIE, VANDECASTEELE CATHERINE. "Correlations entre les donnees du monitoring de la tension arterielle et de l'echocardiogramme : a propos de 64 patients." Lille 2, 1988. http://www.theses.fr/1988LIL2M109.
Full textEvaristi, Maria Franscesca. "New biomarkers and therapeutic targets in left ventricular hypertrophy." Thesis, Toulouse 3, 2017. http://www.theses.fr/2017TOU30047.
Full textLeft ventricular hypertrophy (LVH) is a strong predictor of future heart failure and cardiovascular mortality. Arterial hypertension is considered as the main causative agent for LVH as 30% of hypertensive patients develop LVH. These patients have an increased risk for cardiovascular complications and heart failure. Early diagnosis of LVH and prompt treatment are crucial to reduce LVH and stop its progression towards heart failure. Biomarkers could represent a rapid, effective and low-cost tool to discriminate hypertensive patients with LVH from those with normal LV size. Therefore, we aimed to identify plasma metabolomics biomarkers by 1H NMR to provide novel diagnostic tools for rapid detection of LVH in populations of hypertensive individuals. We realized a cross-sectional study including 48 hypertensive patients with LVH matched with 48 hypertensive patients with normal LV size, and 24 healthy controls. Two-dimensional targeted M-mode echocardiography was performed to measure left ventricular mass index. Partial least squares discriminant analysis was used for the multivariate analysis of the 1H NMR spectral data. From the 1H NMR analysis, we found that the methylene/methyl (-CH2-/-CH3) ratio of aliphatic chain from plasma lipids was significantly increased (p<0.001) in hypertensive patients with LVH compared to hypertensive patients without LVH and to control. Receiver operating characteristic curve showed that a cutoff value of 2.34 provided a 52.08% sensitivity and 85.42% specificity for discriminating LVH (AUC=0.703, p-value<0.001). We propose the -CH2/-CH3 ratio from plasma aliphatic lipid chains as a biomarker for the diagnosis of LVH in arterial hypertension. LVH incidence is also increased in patients with metabolic syndrome (MetS). MetS is defined by central obesity plus any two medical conditions such as dyslipidemia, insulin resistance, and hypertension. These factors synergize to cause LV dysfunction and HF. Published data have shown that MetS patients have low plasma insulin-like growth factor binding protein 2 (IGFBP2). IGFBP2 was shown to play a role in diabetes and metabolism, but studies investigating its role in cardiac diseases are lacking. We first aimed to investigate plasma IGFBP2 levels and cardiac IGFBP2 mRNA levels in MetS patients. Both plasma levels and heart expression levels of IGFBP2 were decreased in patients with MetS compared to control patients. Further, in a C57BL/6J mouse model of 60% high fat diet-induced MetS, we measured cardiac mRNA IGFBP2 levels. According to the observed data in human, mice with MetS showed a decreased cardiac IGFBP2 mRNA level. Finally, we investigated whether a gene therapy strategy using adeno-associated virus 9 carrying human IGFBP2 coding sequence (AAV9-hIGFBP2) could prevent from MetS associated left ventricular hypertrophy. Our data showed that AAV9-hIGFBP2 injection restored durably cardiac IGFBP2 levels in mouse heart and prevented from left ventricle wall thickening, hypertrophy and dysfunction. These clinical and animal data suggest that IGFBP2 is a potential new cardiac therapeutic target in MetS
BAILLY, PATRICK. "Courants ioniques membranaires de la phase de repolarisation cardiaque sur un modele humain d'hypertrophie ventriculaire gauche compensee." Clermont-Ferrand 1, 1997. http://www.theses.fr/1997CLF1MM04.
Full textMoureau, Magali. "Marqueurs de risque cardio-vasculaire de l'hypertension artérielle légère à modérée." Montpellier 1, 1995. http://www.theses.fr/1995MON11038.
Full textPouget, François. "Relation entre l'hypertrophie du ventricule gauche et le pic tensionnel a l'effort chez le sujet hypertendu de plus de cinquante-cinq ans." Nice, 1988. http://www.theses.fr/1988NICE6522.
Full textStuyvers, Bruno. "Modélisation et description du comportement instantané de la rigidité du muscle cardiaque : application à l'hypertrophie ventriculaire gauche expérimentale consécutive à une hypertension rénovasculaire chez le rat (modèle 2K-1C R.H.R)." Bordeaux 2, 1991. http://www.theses.fr/1991BOR28154.
Full textBerthelot-Moritz, Fabienne. "Stress oxydant et dysfonction cardiaque dans un modèle expérimental d'intoxication par la cocai͏̈ne." Rouen, 2003. http://www.theses.fr/2003ROUES036.
Full textCocaine abuse causes myocardial dysfunction and induces oxidative stress. The aims of this study was to appreciate the evolution of cardiac hypertrophy induced by a repetitive cocaine use and to know if oxidative stress is responsible of this cardiac injury. Cocaine administered at 7. 5mg/kg twice a day, induced hypertrophy and cardiac dysfunction which appeared at the seventh day and progressed to the fourth week. We demonstrated the persistence of left ventricular dysfunction after cocaine withdrawal which occurred in a context of deficit in antioxidant defense. Cocaine administration induced early NADPH oxidase-driven 02 release which may play an important role in the development and progression of the LV dysfunction described. LV dysfunction was prevented by antioxidant treatment realised by selenite or by the association of vitamin C and E. These results demonstrate the central role of oxidative stress in the cocaine-induced cardiotoxicity
Kurdi, Mazen. "Hypertrophie ventriculaire gauche dans l'hypertension artérielle : analyse transcriptomique et gènes candidats chez le rat." Lyon 1, 2004. http://www.theses.fr/2004LYO10067.
Full textPasquié, Jean-Luc. "Hypertrophie cardiaque dans l'hypertension artérielle expérimentale et humaine : rôle du sodium alimentaire et de la bradykinine." Montpellier 1, 1997. http://www.theses.fr/1997MON1T027.
Full textPagé, Anik. "Effets des anomalies métaboliques associées à l'obésité viscérale sur la géométrie et la fonction ventriculaire gauche des patients atteints de sténose valvulaire aortique." Thesis, Université Laval, 2010. http://www.theses.ulaval.ca/2010/27747/27747.pdf.
Full textMouchonière, Maud. "Effets de l'hypertrophie sur l'adaptation du potentiel d'action cardiaque aux changements de frequence chez l'homme et le rat." Clermont-Ferrand 1, 1994. http://www.theses.fr/1994CLF1MM10.
Full textSahun, Frédéric. "Valeur pronostique de l'hypertrophie ventriculaire gauche et de la mesure ambulatoire de la pression artérielle dans la survenue des complications cardio-vasculaires chez le sujet hypertendu." Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M137.
Full textCourand, Pierre-Yves. "De la valeur pronostique du coeur et des vaisseaux à l’interaction coeur-vaisseaux." Thesis, Lyon 1, 2015. http://www.theses.fr/2015LYO10158/document.
Full textRisk stratification in hypertension is related to the level of systolic blood pressure (SBP) and diastolic blood pressure (DBP) but also to the presence of subclinical target organ damages. The aims of the studies conducted were to determine the prognostic values of left ventricular and aortic remodeling in the clinical setting of cardiovascular disease. Results were obtained in our historic OLD-HTA cohort started in the 70’s and with patients currently treated in our cardiology department. Regarding left ventricular remodeling, we demonstrated that R wave in aVL lead from the electrocardiogram is a robust index of left ventricular hypertrophy using cardiac MRI and this index is also a powerful predictor of all-cause and cardiovascular mortality in hypertension. Moreover, our results indicated that at a specific level of SBP, a low DBP is harmful in the presence of aortic atheroma. Therefore, aortic atherosclerosis or aortic calcifications are a major predictor of cardiovascular events after transcutaneous aortic valve implantation and in hypertensive patients with high resting heart rate. Taken together these data emphasize the interplay between aorta and the heart and provide some new hints to improve risk stratification particularly in hypertension
Zendaoui, Adnane. "Efficacité du carvédilol sur l'hypertrophie ventriculaire gauche et la fonction cardiaque chez des rats ayant une insuffisance aortique chronique sévère." Thesis, Université Laval, 2011. http://www.theses.ulaval.ca/2011/28108/28108.pdf.
Full textPlante, Éric. "Rôle du système neurohormonal dans le développement de l'hypertrophie ventriculaire gauche chez le rat insuffisant aortique chronique." Thesis, Université Laval, 2008. http://www.theses.ulaval.ca/2008/25767/25767.pdf.
Full textTrouvé, Pascal. "Rôles joués par l'ATPase sodium-potassium et l'Annexine V sur la régulation calcique au cours de la transition de l'hypertrophie ventriculaire gauche compensée vers l'insuffisance cardiaque." Paris 5, 2000. http://www.theses.fr/2000PA05S005.
Full textAzancot-Benisti, Anabelle. "Intéraction du ventricule droit et du ventricule gauche : mécanique du ventricule gauche." Paris 12, 1990. http://www.theses.fr/1990PA120032.
Full textFradin, de la Renaudière Dominique. "Endoanévrysmographie remodelante pour anévrysmes du ventricule gauche." Bordeaux 2, 1990. http://www.theses.fr/1990BOR23090.
Full textRouxel, Marie-France. "Anévrysmes ou diverticules congénitaux du ventricule gauche, à propos de deux cas cliniques, revue de la littérature." Bordeaux 2, 1996. http://www.theses.fr/1996BOR2M033.
Full textCirtina, Bonciu Claudia. "Restitution 4d du ventricule gauche du cur par echocardiographie." Orléans, 1997. http://www.theses.fr/1997ORLE2030.
Full textMedina, Ruben. "Reconstruction tridimensionnelle du ventricule gauche en angiographie bi-plan." Rennes 1, 1998. http://www.theses.fr/1999REN10166.
Full textFEUILLAT, RICHEBOURG SYLVIE. "Fonction ventriculaire droite chez 56 sujets temoins : etude par angioscintigraphie a l'equilibre et comparaison avec le ventricule gauche." Dijon, 1994. http://www.theses.fr/1994DIJOM031.
Full textKaram, Elias. "Hypertrophie ventriculaire gauche du retrecissement aortique : evolution apres l'intervention." Université Louis Pasteur (Strasbourg) (1971-2008), 1986. http://www.theses.fr/1986STR1M242.
Full textKOZAK, JEROME. "Myxome du ventricule gauche : a propos d'une observation et revue de la litterature." Lille 2, 1992. http://www.theses.fr/1992LIL2M313.
Full textPignotti, René-Pierre. "Digoxine et fonction ventriculaire gauche de la personne agee." Bordeaux 2, 1988. http://www.theses.fr/1988BOR25288.
Full textKALTENBACH, EDMOND. "Scintigraphie cavitaire gauche : analyse de courbes temps activite." Besançon, 1990. http://www.theses.fr/1990BESA3039.
Full textMinviole, Thierry. "Impact de l'athérectomie coronaire sur la fonction segmentaire du ventricule gauche." Bordeaux 2, 1996. http://www.theses.fr/1996BOR23060.
Full textWinterfeldt, Götz. "Reconstruction dynamique du ventricule gauche à partir de séquences d'images échographiques." Nancy 1, 1999. http://www.theses.fr/1999NAN10041.
Full textBensadoun, René-Jean. "Effet myocardique aigu de l'irradiation mediastinale : evolution de la fraction d'ejection ventriculaire gauche au cours et au decours de l'irradation ; etude prospective sur 127 patients traites au c.a.l. entre 1986 et 1989." Nice, 1989. http://www.theses.fr/1989NICE6810.
Full textJOECKER, VINCENT. "Etude de la fonction ventriculaire gauche systolique et diastolique par ventriculographie isotopique a l'equilibre." Toulouse 3, 1990. http://www.theses.fr/1990TOU31237.
Full textLIVAREK, BERNARD RAPHAEL. "Fonction ventriculaire gauche apres thrombolyse intraveineuse : evaluation globale et segmentaire avec un recul moyen de huit mois." Toulouse 3, 1988. http://www.theses.fr/1988TOU31301.
Full textVALLA, JEAN. "Contribution a l'etude du traitement chirurgical des anevrysmes du ventricule gauche : a propos d'une serie de 121 patients operes au chu de rennes entre 1978 et 1992." Rennes 1, 1994. http://www.theses.fr/1994REN1M024.
Full textAzouani, Abdelhamid. "Mesure par imagerie des déformations d'une structure : application à l'analyse dynamique de la géométrie du ventricule gauche." Paris 12, 1987. http://www.theses.fr/1987PA120037.
Full textDUMONCEAU, TONY, and JEAN-PIERRE HANON. "Le ventricule gauche a double issue : a propos de trois observations, ses caracteristiques : a propos d'une revue de la litterature." Lille 2, 1988. http://www.theses.fr/1988LIL2M247.
Full textSu, Jinbo. "Mécanique cardiaque : la contraction et la relaxation ventriculaires gauches du coeur in-situ." Paris 12, 1991. http://www.theses.fr/1991PA120052.
Full textLéger, Christophe. "Contribution au suivi volumique en temps réel du ventricule gauche par échocardiographie." Phd thesis, Université d'Orléans, 1993. http://tel.archives-ouvertes.fr/tel-00607860.
Full text